Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00894
Species: Homo sapiens
Position : chr2:16619625-16621501
Year: 2023
Title: TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: T-cell acute lymphoblastic leukemia
PMID:  37591943
MONDO: MONDO:0004963
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: RPMI-8402
CVCL ID: CVCL_1667
Cell Type: T lymphoblast
Cell Ontology ID: CL:0000084
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: ChIP-seq; ATAC-seq; Hi-C, 4C-seq
Low Throughput Method: Luciferase Reporter Assay; CRISPR Knockout; CRISPRi; ChIP-RT-qPCR; RT-RT-qPCR; Western blot
About Target Gene
Target gene : MYCN
About TF
TF name : TAL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00893 chr2:16619625-16621501 blood T lymphoblast T-cell acute lymphoblastic leukemia
E_00895 chr2:16619625-16621501 blood T cell T-cell acute lymphoblastic leukemia
E_00899 chr2:16619625-16621501 blood T cell T-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer